TOMASELLO, Gianluca
 Distribuzione geografica
Continente #
NA - Nord America 286
EU - Europa 253
AS - Asia 84
Totale 623
Nazione #
US - Stati Uniti d'America 284
IE - Irlanda 83
SE - Svezia 76
CN - Cina 72
IT - Italia 36
FI - Finlandia 32
DE - Germania 14
TR - Turchia 5
BE - Belgio 3
CZ - Repubblica Ceca 3
FR - Francia 3
IN - India 3
CA - Canada 2
IR - Iran 2
SG - Singapore 2
NL - Olanda 1
RU - Federazione Russa 1
UA - Ucraina 1
Totale 623
Città #
Chandler 90
Dublin 83
New York 30
Ann Arbor 21
Ashburn 18
Dearborn 17
Parma 16
Shanghai 15
Princeton 13
Nanjing 11
Beijing 9
Bremen 6
Jinan 6
Helsinki 5
Izmir 5
Seattle 5
Wilmington 4
Boardman 3
Brussels 3
Changsha 3
Hebei 3
Hefei 3
Nanchang 3
Shenyang 3
Woodbridge 3
Fremont 2
Guangzhou 2
Mestre 2
Modena 2
Norwalk 2
Pune 2
Tianjin 2
Carlentini 1
Casalgrande 1
Des Moines 1
Fayetteville 1
Fuzhou 1
Haikou 1
Hangzhou 1
Henderson 1
Jiaxing 1
Lanzhou 1
Leawood 1
Ningbo 1
Ottawa 1
Redwood City 1
Rio Saliceto 1
Rockville 1
San Mateo 1
Taiyuan 1
Taizhou 1
Toronto 1
Verona 1
Vladikavkaz 1
Xian 1
Totale 415
Nome #
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 86
Notch expression and bevacizumab efficacy in colorectal cancer patients 74
P-027Cancer stem cells marker CD44 and Notch activation predict unfavorable prognosis in metastatic colon cancer patients treated with anti VEGF-therapy 69
Strong Notch activation hinders bevacizumab efficacy in advanced colorectal cancer 68
Cancer stem cells related marker CD44 and Notch activation in metastatic colon cancer patients 58
Notch Activation Modulates Bevacizumab Activity by CD44 Positive Cancer Stem Cells in Advanced Colon Cancer 54
Immunotherapy options in metastatic renal cell cancer: Where we are and where we are going 39
Phase III, randomised, multicentre trial of maintenance immunotherapy with low-dose interleukin-2 and interferon-α for metastatic renal cell cancer 38
Oxaliplatin-induced hemolytic anemia during adjuvant treatment of a patient with colon cancer: A case report 35
A pilot phase II study of chemotherapy with oxaliplatin, folinic acid, 5-fluorouracil and irinotecan in metastatic gastric cancer 33
Tamoxifen vs Tamoxifen plus 13-cis-retinoic acid vs Tamoxifen plus Interferon α-2a as first-line endocrine treatments in advanced breast cancer: Updated results of a phase II, prospective, randomised multicentre trial 31
Dose-dense chemotherapy in metastatic gastric cancer with a modified docetaxel-cisplatin-5-fluorouracil regimen 30
Sequential chemotherapy with dose-dense docetaxel, cisplatin, folinic acid and 5-fluorouracil (TCF-dd) followed by combination of oxaliplatin, folinic acid, 5-fluorouracil and irinotecan (COFFI) in metastatic gastric cancer: Results of a phase II trial 28
Totale 643
Categoria #
all - tutte 2.434
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.434


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 0 0 6 3
2019/202085 13 5 0 7 6 18 7 2 4 23 0 0
2020/202135 3 1 1 1 4 3 1 7 6 2 5 1
2021/202256 2 0 0 5 2 0 12 2 1 3 4 25
2022/2023283 34 42 19 17 17 32 4 16 92 0 9 1
2023/202492 0 13 1 1 5 50 11 5 3 3 0 0
Totale 643